125 related articles for article (PubMed ID: 20457798)
21. Nuchal translucency and nasal bone for trisomy 21 screening: single center experience.
Monni G; Zoppi MA; Ibba RM; Floris M; Manca F; Axiana C
Croat Med J; 2005 Oct; 46(5):786-91. PubMed ID: 16158472
[TBL] [Abstract][Full Text] [Related]
22. Fetal nasal bone in screening for trisomies 21, 18 and 13 and Turner syndrome at 11-13 weeks of gestation.
Kagan KO; Cicero S; Staboulidou I; Wright D; Nicolaides KH
Ultrasound Obstet Gynecol; 2009 Mar; 33(3):259-64. PubMed ID: 19248005
[TBL] [Abstract][Full Text] [Related]
23. Aberrant lymphatic development in euploid fetuses with increased nuchal translucency including Noonan syndrome.
de Mooij YM; van den Akker NM; Bekker MN; Bartelings MM; van Vugt JM; Gittenberger-de Groot AC
Prenat Diagn; 2011 Feb; 31(2):159-66. PubMed ID: 21268034
[TBL] [Abstract][Full Text] [Related]
24. Screening for trisomies in dichorionic twins by measurement of fetal nuchal translucency thickness according to the mixture model.
Wright D; Syngelaki A; Staboulidou I; Cruz Jde J; Nicolaides KH
Prenat Diagn; 2011 Jan; 31(1):16-21. PubMed ID: 21210476
[TBL] [Abstract][Full Text] [Related]
25. [Increased nuchal translucency and cystic hygroma in the first trimester: prenatal diagnosis and neonatal outcome].
Ducarme G; Graesslin O; Alanio E; Bige V; Gaillard D; Gabriel R
Gynecol Obstet Fertil; 2005 Oct; 33(10):750-4. PubMed ID: 16139544
[TBL] [Abstract][Full Text] [Related]
26. Distribution of extracellular matrix components in nuchal skin from fetuses carrying trisomy 18 and trisomy 21.
Brand-Saberi B; Epperlein HH; Romanos GE; Christ B
Cell Tissue Res; 1994 Sep; 277(3):465-75. PubMed ID: 7954686
[TBL] [Abstract][Full Text] [Related]
27. Ductus venosus Doppler in screening for trisomies 21, 18 and 13 and Turner syndrome at 11-13 weeks of gestation.
Maiz N; Valencia C; Kagan KO; Wright D; Nicolaides KH
Ultrasound Obstet Gynecol; 2009 May; 33(5):512-7. PubMed ID: 19338027
[TBL] [Abstract][Full Text] [Related]
28. Nuchal fold thickness, nasal bone absence or hypoplasia, ductus venosus reversed flow and tricuspid valve regurgitation in screening for trisomies 21, 18 and 13 in the early second trimester.
Geipel A; Willruth A; Vieten J; Gembruch U; Berg C
Ultrasound Obstet Gynecol; 2010 May; 35(5):535-9. PubMed ID: 20183867
[TBL] [Abstract][Full Text] [Related]
29. The use of nuchal translucency in contemporary obstetric practice.
Said S; Malone FD
Clin Obstet Gynecol; 2008 Mar; 51(1):37-47. PubMed ID: 18303498
[TBL] [Abstract][Full Text] [Related]
30. Absence of an anatomical origin for altered ductus venosus flow velocity waveforms in first-trimester human fetuses with increased nuchal translucency.
Burger NB; Matias A; Kok E; de Groot CJ; Christoffels VM; Bekker MN; Haak MC
Prenat Diagn; 2016 Jun; 36(6):537-44. PubMed ID: 27060369
[TBL] [Abstract][Full Text] [Related]
31. [Study on several ultrasound markers combined maternal serum biochemical markers to screen fetal chromosomal aneuploidy at 11 to 13(+)6 weeks of gestation].
Chen X; Chang Y; Cui HY; Ren CC; Yu BY
Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):815-8. PubMed ID: 24444556
[TBL] [Abstract][Full Text] [Related]
32. First-trimester screening for trisomies 21, 18 and 13 by ultrasound and biochemical testing.
Wright D; Syngelaki A; Bradbury I; Akolekar R; Nicolaides KH
Fetal Diagn Ther; 2014; 35(2):118-26. PubMed ID: 24356462
[TBL] [Abstract][Full Text] [Related]
33. Changes in nuchal translucency thickness in normal and abnormal karyotype fetuses.
Zoppi MA; Ibba RM; Floris M; Manca F; Axiana C; Monni G
BJOG; 2003 Jun; 110(6):584-8. PubMed ID: 12798476
[TBL] [Abstract][Full Text] [Related]
34. First-trimester screening for chromosomal abnormalities by integrated application of nuchal translucency, nasal bone, tricuspid regurgitation and ductus venosus flow combined with maternal serum free β-hCG and PAPP-A: a 5-year prospective study.
Ghaffari SR; Tahmasebpour AR; Jamal A; Hantoushzadeh S; Eslamian L; Marsoosi V; Fattahi F; Rajaei M; Niroomanesh S; Borna S; Beigi A; Khazardoost S; Saleh-Gargari S; Rahimi-Sharbaf F; Farrokhi B; Bayani N; Tehrani SE; Shahsavan K; Farzan S; Moossavi S; Ramezanzadeh F; Dastan J; Rafati M
Ultrasound Obstet Gynecol; 2012 May; 39(5):528-34. PubMed ID: 21793085
[TBL] [Abstract][Full Text] [Related]
35. Accuracy of first-trimester combined test in screening for trisomies 21, 18 and 13.
Santorum M; Wright D; Syngelaki A; Karagioti N; Nicolaides KH
Ultrasound Obstet Gynecol; 2017 Jun; 49(6):714-720. PubMed ID: 27549925
[TBL] [Abstract][Full Text] [Related]
36. Collagen type VI gene expression in the skin of trisomy 21 fetuses.
von Kaisenberg CS; Brand-Saberi B; Christ B; Vallian S; Farzaneh F; Nicolaides KH
Obstet Gynecol; 1998 Mar; 91(3):319-23. PubMed ID: 9491853
[TBL] [Abstract][Full Text] [Related]
37. Detection of fetal chromosomal anomalies: does nuchal translucency measurement have added value in the era of non-invasive prenatal testing?
Lichtenbelt KD; Diemel BD; Koster MP; Manten GT; Siljee J; Schuring-Blom GH; Page-Christiaens GC
Prenat Diagn; 2015 Jul; 35(7):663-8. PubMed ID: 25754604
[TBL] [Abstract][Full Text] [Related]
38. Nuchal translucency and lymphatic system maldevelopment.
Bellini C; Rutigliani M; Boccardo FM; Bonioli E; Campisi C; Grillo F; Bellini T; Valenzano M; Fulcheri E
J Perinat Med; 2009; 37(6):673-6. PubMed ID: 19591554
[TBL] [Abstract][Full Text] [Related]
39. Fetal heart rate in chromosomally abnormal fetuses.
Liao AW; Snijders R; Geerts L; Spencer K; Nicolaides KH
Ultrasound Obstet Gynecol; 2000 Dec; 16(7):610-3. PubMed ID: 11169365
[TBL] [Abstract][Full Text] [Related]
40. Quantitative evaluation of collagen type VI and SOD gene expression in the nuchal skin of human fetuses with trisomy 21.
Quarello E; Guimiot F; Moalic JM; Simoneau M; Ville Y; Delezoide AL
Prenat Diagn; 2007 Oct; 27(10):926-31. PubMed ID: 17602442
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
